We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.32B
AUM Growth
+$155M
Cap. Flow
-$100M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.3%
Holding
739
New
50
Increased
312
Reduced
249
Closed
35

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$31M
2
CL icon
Colgate-Palmolive
CL
+$20M
3
MRK icon
Merck
MRK
+$18.8M
4
GLW icon
Corning
GLW
+$18.5M
5
FFIV icon
F5
FFIV
+$17.2M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$40.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38M
3
META icon
Meta Platforms (Facebook)
META
+$23.2M
4
ORCL icon
Oracle
ORCL
+$20.4M
5
MJN
Mead Johnson Nutrition Company
MJN
+$20.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.58%
2 Technology 13.62%
3 Financials 13.2%
4 Consumer Discretionary 9.51%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRP icon
426
TC Energy
TRP
$73.5B
$2.29M 0.04%
48,045
-7,443
-13% -$350K
GBT
427
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.27M 0.04%
83,000
+6,000
+8% +$179K
AKRX
428
DELISTED
Akorn Inc
AKRX
$2.21M 0.04%
66,000
+26,000
+65% +$847K
TGTX icon
429
TG Therapeutics
TGTX
$8.58B
$2.21M 0.04%
220,000
-95,000
-30% -$1.06M
TU icon
430
Telus
TU
$16B
$2.21M 0.04%
128,154
+34,684
+37% +$582K
SIOX
431
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2.16M 0.04%
11,625
-8,375
-42% -$1.47M
STZ icon
432
Constellation Brands
STZ
$22.2B
$2.15M 0.04%
11,104
-622
-5% -$111K
BIO icon
433
Bio-Rad Laboratories Class A
BIO
$8.42B
$2.15M 0.04%
9,500
– –
EG icon
434
Everest Group
EG
$15.2B
$2.15M 0.04%
8,432
+4,486
+114% +$1.11M
AGEN
435
Agenus
AGEN
$249M
$2.14M 0.04%
27,905
– –
CMS icon
436
CMS Energy
CMS
$23.1B
$2.14M 0.04%
46,292
+541
+1% +$25K
LVLT
437
DELISTED
Level 3 Communications Inc
LVLT
$2.12M 0.04%
35,740
-33,052
-48% -$1.99M
AERI
438
DELISTED
Aerie Pharmaceuticals
AERI
$2.1M 0.04%
40,000
+10,000
+33% +$466K
EQIX icon
439
Equinix
EQIX
$107B
$2.1M 0.04%
4,896
-537
-10% -$228K
MGM icon
440
MGM Resorts International
MGM
$11.7B
$2.09M 0.04%
66,864
-3,679
-5% -$114K
AVB icon
441
AvalonBay Communities
AVB
$27.1B
$2.07M 0.04%
10,780
+1,877
+21% +$359K
IQV icon
442
IQVIA
IQV
$34.7B
$2.05M 0.04%
22,950
+637
+3% +$53.8K
AVXS
443
DELISTED
AveXis, Inc. Common Stock
AVXS
$2.05M 0.04%
25,000
– –
TRI icon
444
Thomson Reuters
TRI
$39.4B
$2.04M 0.04%
38,049
+1,763
+5% +$90.4K
PAYX icon
445
Paychex
PAYX
$40.4B
$2.04M 0.04%
35,748
+688
+2% +$40.4K
ROP icon
446
Roper Technologies
ROP
$36.3B
$2.04M 0.04%
8,793
-2,299
-21% -$509K
SLF icon
447
Sun Life Financial
SLF
$45.6B
$2.03M 0.04%
56,941
-417
-0.7% -$14.4K
GPC icon
448
Genuine Parts
GPC
$17.1B
$2.03M 0.04%
21,879
+3,015
+16% +$277K
EA icon
449
Electronic Arts
EA
$52.4B
$2.01M 0.04%
18,976
+517
+3% +$53.2K
ES icon
450
Eversource Energy
ES
$28.2B
$1.99M 0.04%
32,833
+9,514
+41% +$578K
16 17
18
19 20

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2017 Portfolio in Review

As of Q2 2017, Candriam SCA held 739 positions worth $5.32B, up 3% from $5.17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q2 2017 filing shows 50 new, 312 increased, 249 reduced and 35 closed positions. Its largest new stake was Raymond James Financial: 164,790 shares worth $8.81M. The largest sale was PepsiCo, an estimated $40.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2017 buy was Raymond James Financial: 164,790 shares worth $8.81M.
  • Candriam SCA added most to Kellanova in Q2 2017, an estimated $31M increase.
  • Candriam SCA's biggest Q2 2017 reduction was PepsiCo, cutting an estimated $40.4M.
  • Candriam SCA fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $20.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.32B portfolio in Q2 2017.
  • Candriam SCA opened 50 new positions and closed 35 in Q2 2017.
  • Candriam SCA's portfolio value rose 3% quarter-over-quarter to $5.32B.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.